4-(3-(5-bromo-2-hydroxybenzylideneamino)propyl)-1H-pyrazol-5(4H)-one

ID: ALA3286624

Chembl Id: CHEMBL3286624

PubChem CID: 332170

Max Phase: Preclinical

Molecular Formula: C13H14BrN3O2

Molecular Weight: 324.18

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NN=CC1CCC/N=C/c1cc(Br)ccc1O

Standard InChI:  InChI=1S/C13H14BrN3O2/c14-11-3-4-12(18)10(6-11)7-15-5-1-2-9-8-16-17-13(9)19/h3-4,6-9,18H,1-2,5H2,(H,17,19)/b15-7+

Standard InChI Key:  UDFIUIDTCIVMIF-VIZOYTHASA-N

Associated Targets(non-human)

Streptococcus sp. 'group A' (3417 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 324.18Molecular Weight (Monoisotopic): 323.0269AlogP: 2.09#Rotatable Bonds: 5
Polar Surface Area: 74.05Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.46CX Basic pKa: 5.73CX LogP: 2.06CX LogD: 2.01
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.64Np Likeness Score: -0.16

References

1. Hu H, Mao S, Bugrysheva JV, Pruett S, Liotta DC, Scott JR, Snyder JP..  (2014)  Group A streptococcus inhibitors by high-throughput virtual screening.,  82  [PMID:24880231] [10.1016/j.ejmech.2014.05.006]

Source